Why the study?
The use of adeno-associated virus vectors for gene function studies and gene therapy is often hampered because the viruses are not readily available.
Provides a simple, scalable method for producing AAV vectors for preclinical and clinical gene therapy applications.
No takes yet. Share an insight, caveat, or question.
Simplifies AAV access for brain gene studies in mice; leaves open comparative validation before wider preclinical use.
Chen et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: